ARCHIVES

EORTC Screening, Pharmacology Group Focuses On CNU

This article is from The Cancer Letter archive.

Vol. 13 No. 01 | January 2, 1987

Download PDF Visit The Full Archive

Related Articles

Tasigna Shows High Response, PFS Benefit Compared to Gleevec in Phase III CML Study

December 26, 2014

Virus Program Scientific Activities Report Concluded

August 22, 1975

FDA News: Agency Accepting Nominations For Patient Representatives

May 8, 1998

Abstracts Of Papers Presented By Breast Cancer Task Force

August 27, 1976

CCOP RFA Response So Far Points To More Consortia Applications, Reasonable Geographic Distribution

August 20, 1982

NCI Grant Funding Payline To Begin At 16th Percentile In FY 2010

December 11, 2009